1[1]Vyavahare NR, Chen W, Joshi RR et al. Current progress in anticalcification for bioprosthetic and polymeric heart valve. Cardiovasc Pathol, 1997；6(4):219～229
2[2]Shanthi C, Panduranga RK. Regulation of biocalcification of bovine pericardial tissue by grafting poly (glycidyl methacrylatebutylacry-late) copolymers. J Bioact Compat Polym, 1997；12(4):308～320
3[3]Stacchino C, Bona G, Bonettic F et al. Detoxification process for Glutaraldehyde-treated bovine pericardium: Biological, chemical and mechanical characterization.J Heart Valve Dis, 1998；7(2):190～194
4[4]Gott JP, Girardot MN, Girardot JMD et al. Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. Ann Thorac Surg,1997；64(1):50～58
5[5]Langdon SE,Chernecky R,Pereira CA et al.Biaxial mechenical structural effects of equibiaxial strain during crosslinking of bovine pericardial xenograft materials. Biomaterials,1999；20:137～153
6[6]Kent PD, Tazelaar HD, Edwards WD et al. Temporal changes in the surgical pathology of prosthetic aortic valve: a study of 157 cases spanning 26 years (1970～1995). Cardiovasc Pathol, 1998；7(1):9～23
7[7]Zilla P, Fullard L, Trescony P et al. Glutaraldehyde detoxification of aortic wall tissue: a promising perspective for emerging bioprosthetic valve concepts. J Heart Valve Dis, 1997；6(5):510～520
8[8]Lehner G, Fischlein T, Baratton G et al. Endothelialized biological heart valve prostheses in the non-human primate model. Eur J Cardio Thorac Surg, 1997；11(3):498～504
9[9]Curtil A, Pagg DE, Wilson A. Repopulation of freeze-dried porcine valve with human fibroblasts and endothelial cells. J Heart Valve Dis, 1997；6(3):296～306
10[10]Toshiharu S, Dominique ST, Peter XM et al. Tissue-engineered heart valve leaflets, does cell origin affect outcome? Circulation, 1997；96(2 suppl):Ⅱ102～Ⅱ107
